Edwards Lifesciences Corp Stock Probability of Future Stock Price Finishing Over 132.91

EW Stock  USD 95.15  1.73  1.85%   
Edwards Lifesciences' implied volatility is one of the determining factors in the pricing options written on Edwards Lifesciences Corp. Implied volatility approximates the future value of Edwards Lifesciences based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Edwards Lifesciences Corp over a specific time period. For example, 2024-04-19 CALL at $95.0 is a CALL option contract on Edwards Lifesciences' common stock with a strick price of 95.0 expiring on 2024-04-19. The contract was last traded on 2024-03-27 at 15:36:06 for $2.4 and, as of today, has 22 days remaining before the expiration. The option is currently trading at a bid price of $2.35, and an ask price of $2.55. The implied volatility as of the 28th of March is 23.29. View All Edwards options

Closest to current price Edwards long CALL Option Payoff at Expiration

Edwards Lifesciences' future price is the expected price of Edwards Lifesciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Edwards Lifesciences Corp performance during a given time horizon utilizing its historical volatility. Check out Edwards Lifesciences Backtesting, Edwards Lifesciences Valuation, Edwards Lifesciences Correlation, Edwards Lifesciences Hype Analysis, Edwards Lifesciences Volatility, Edwards Lifesciences History as well as Edwards Lifesciences Performance.
  
At this time, Edwards Lifesciences' Price To Operating Cash Flows Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to climb to 77.16 in 2024, whereas Price To Sales Ratio is likely to drop 4.36 in 2024. Please specify Edwards Lifesciences' target price for which you would like Edwards Lifesciences odds to be computed.

Edwards Lifesciences Target Price Odds to finish over 132.91

The tendency of Edwards Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 132.91  or more in 90 days
 95.15 90 days 132.91 
near 1
Based on a normal probability distribution, the odds of Edwards Lifesciences to move over $ 132.91  or more in 90 days from now is near 1 (This Edwards Lifesciences Corp probability density function shows the probability of Edwards Stock to fall within a particular range of prices over 90 days) . Probability of Edwards Lifesciences Corp price to stay between its current price of $ 95.15  and $ 132.91  at the end of the 90-day period is about 5.52 .
Allowing for the 90-day total investment horizon Edwards Lifesciences has a beta of 0.72 suggesting as returns on the market go up, Edwards Lifesciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Edwards Lifesciences Corp will be expected to be much smaller as well. Additionally Edwards Lifesciences Corp has an alpha of 0.2828, implying that it can generate a 0.28 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Edwards Lifesciences Price Density   
       Price  

Predictive Modules for Edwards Lifesciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Edwards Lifesciences Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edwards Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
93.1895.2997.40
Details
Intrinsic
Valuation
LowRealHigh
85.6498.49100.60
Details
Naive
Forecast
LowNextHigh
93.5195.6297.74
Details
31 Analysts
Consensus
LowTargetHigh
83.1191.33101.38
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Edwards Lifesciences. Your research has to be compared to or analyzed against Edwards Lifesciences' peers to derive any actionable benefits. When done correctly, Edwards Lifesciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Edwards Lifesciences Corp.

Edwards Lifesciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Edwards Lifesciences is not an exception. The market had few large corrections towards the Edwards Lifesciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Edwards Lifesciences Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Edwards Lifesciences within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.28
β
Beta against NYSE Composite0.72
σ
Overall volatility
7.55
Ir
Information ratio 0.12

Edwards Lifesciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Edwards Lifesciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Edwards Lifesciences Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Over 84.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Disposition of 6320 shares by Lippis Daniel J. of Edwards Lifesciences at 88.78 subject to Rule 16b-3

Edwards Lifesciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Edwards Stock often depends not only on the future outlook of the current and potential Edwards Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Edwards Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding609.4 M
Cash And Short Term Investments1.6 B

Edwards Lifesciences Technical Analysis

Edwards Lifesciences' future price can be derived by breaking down and analyzing its technical indicators over time. Edwards Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Edwards Lifesciences Corp. In general, you should focus on analyzing Edwards Stock price patterns and their correlations with different microeconomic environments and drivers.

Edwards Lifesciences Predictive Forecast Models

Edwards Lifesciences' time-series forecasting models is one of many Edwards Lifesciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Edwards Lifesciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Edwards Lifesciences Corp

Checking the ongoing alerts about Edwards Lifesciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Edwards Lifesciences Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 84.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Disposition of 6320 shares by Lippis Daniel J. of Edwards Lifesciences at 88.78 subject to Rule 16b-3
When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.3
Revenue Per Share
9.897
Quarterly Revenue Growth
0.138
Return On Assets
0.1225
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.